Article Text

Download PDFPDF
Case report
Complete robotic intervention for acute epistaxis in a patient with COVID-19 pneumonia: technical considerations and device selection tips
  1. Hamidreza Saber1,
  2. Charles Beaman2,
  3. Satoshi Tateshima1,3
  1. 1 Interventional Neuroradiology, UCLA, Los Angeles, California, USA
  2. 2 Neurology, UCLA Medical Center, Los Angeles, California, USA
  3. 3 Radiological Sciences, UCLA, Los Angeles, California, USA
  1. Correspondence to Dr Satoshi Tateshima, Interventional Neuroradiology, Radiological Sciences, UCLA, Los Angeles, California, USA; stateshima{at}


The use of robot-assisted technology is expanding in interventional laboratories with an increasing number of reports of effective treatment delivery in neurointerventional procedures. Here we report the feasibility of complete robot-assisted neurointervention including the guide catheter and microcatheter manipulations with subsequent embolization of the arterial source of hemorrhage in a patient hospitalized with severe COVID-19 complicated by acute epistaxis.

  • COVID-19
  • angiography
  • technique
  • technology
  • intervention

This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter @charlesbeaman

  • Contributors HS and ST contributed to the conception or design of the work. HS, ST and CB contributed to drafting the work and revising it critically for important intellectual content.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests ST: Corindus Vascular Robotics: advisory board, shareholder from 2018-2019. Currently no relationship. HS and CB have nothing to disclose.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.